FDA OKs first generic version of drug to treat low blood sugar

Dec. 29, 2020

The FDA has green lighted the first-ever generic version of glucagon for injection to treat hypoglycemia, or dangerously low blood sugar.

Severe hypoglycemia is most common in patients with diabetes who are taking insulin. The condition can cause confusion or render the patient unconscious and in need of immediate assistance from another person.

Although glucagon has been approved in the U.S. for over 20 years, a generic version of the drug has never been approved. The new approval will make glucagon more affordable for caretakers of diabetes patients and for First Aid kits.

Read the FDA press release.